Ela Sauerborn

Ela Sauerborn

Auto-generated profile, based on publicly available information

Ela Sauerborn

Department of Preclinical Medicine, Institute of Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ESEla Sauerborn
Ela Sauerborn
NCNancy Carolina Corredor
Nancy Carolina Corredor
TRTim Reska
Tim Reska
APAlbert Perlas
Albert Perlas
SASamir Vargas da Fonseca Atum
Samir Vargas da Fonseca Atum
LULara Urban
Lara Urban
Real-time genomics through nanopore sequencing holds the promise of fast antibiotic resistance prediction directly in the clinical setting. However, concerns about the accuracy of genomics-based resistance predictions persist, particularly when compared to traditional, clinically established diagnostic methods. Here, we leverage the case of a multi-drug resistant Klebsiella pneumoniae infection to demonstrate how real-time genomics can enhance the accuracy of antibiotic resistance profiling in complex infection scenarios. Our results show that unlike established diagnostics, nanopore sequencing data analysis can accurately detect low-abundance plasmid-mediated resistance, which often remains undetected by conventional methods. This capability has direct implications for clinical practice, where such “hidden” resistance profiles can critically influence treatment decisions. Consequently, the rapid, in situ application of real-time genomics holds significant promise for improving clinical decision-making and patient outcomes.

6 January 2025 in GigaScience
Verified
Journal Article
Open access
HÜHarika Ürel
Harika Ürel
SBSabrina Benassou
Sabrina Benassou
HMHanna Marti
Hanna Marti
TRTim Reska
Tim Reska
ESEla Sauerborn
Ela Sauerborn
LULara Urban
Lara Urban
Background: The ability to differentiate between viable and dead microorganisms in metagenomic data is crucial for various microbial inferences, ranging from assessing ecosystem functions of environmental microbiomes to inferring the virulence of potential pathogens from metagenomic analysis. Established viability-resolved genomic approaches are labor-intensive as well as biased and lacking in sensitivity. Results: We here introduce a new fully computational framework that leverages nanopore sequencing technology to assess microbial viability directly from freely available nanopore signal data. Our approach utilizes deep neural networks to learn features from such raw nanopore signal data that can distinguish DNA from viable and dead microorganisms in a controlled experimental setting of UV-induced Escherichia cell death. The application of explainable artificial intelligence (AI) tools then allows us to pinpoint the signal patterns in the nanopore raw data that allow the model to make viability predictions at high accuracy. Using the model predictions as well as explainable AI, we show that our framework can be leveraged in a real-world application to estimate the viability of obligate intracellular Chlamydia, where traditional culture-based methods suffer from inherently high false-negative rates. This application shows that our viability model captures predictive patterns in the nanopore signal that can be utilized to predict viability across taxonomic boundaries. We finally show the limits of our model’s generalizability through antibiotic exposure of a simple mock microbial community, where a new model specific to the killing method had to be trained to obtain accurate viability predictions. Conclusions: While the potential of our computational framework’s generalizability and applicability to metagenomic studies needs to be assessed in more detail, we here demonstrate for the first time the analysis of freely available nanopore signal data to infer the viability of microorganisms, with many potential applications in environmental, veterinary, and clinical settings.

20 October 2021 in Bioethics
Verified
Journal Article
Open access
PDF file
ESEla Sauerborn
Ela Sauerborn
KEKatharina Eisenhut
Katharina Eisenhut
AGAgomoni Ganguli‐Mitra
Agomoni Ganguli‐Mitra
VWVerina Wild
Verina Wild
Mobile applications (apps) have gained significant popularity as a new intervention strategy responding to violence against women and girls. Despite their growing relevance, an assessment from the perspective of public health ethics is still lacking. Here, we base our discussion on the understanding of violence against women and girls as a multidimensional, global public health issue on structural, societal and individual levels and situate it within the theoretical framework of structural injustice, including epistemic injustice. Based on a systematic app review we previously conducted, we evaluate the content and functions of apps through the lens of structural injustice. We argue that technological solutions such as apps may be a useful tool in the fight against violence against women and girls but have to be situated within the broader frame of public health that considers the structural dimensions of such violence. Ultimately, the concerns raised by structural injustice are—alongside key concerns of safety, data privacy, importance of human supportive contact, and so forth—crucial dimensions in the ethical assessment of such apps. However, research on the role and relevance of apps as strategies to address the structural and epistemic dimensions of violence remains scarce. This article aims to provide a foundation for further discussion in this area and could be applicable to other areas in public health policy and practice.

12 February 2026 in Microbial Genomics
Verified
Journal Article
Open access
ESEla Sauerborn
Ela Sauerborn
Rhys Thomas WhiteRhys Thomas White
Rhys Thomas White
AKAnna-Lena Kalteis
Anna-Lena Kalteis
DGDaniel Gygax
Daniel Gygax
EFEbenezer Foster-Nyarko
Ebenezer Foster-Nyarko
LULara Urban
Lara Urban
The growing resistance of Enterobacterales to last-resort antibiotics such as carbapenems puts a significant burden on healthcare systems, also due to plasmids driving a rapid spread of carbapenem resistance. We here evaluate the use of long-read nanopore sequencing to investigate carbapenem resistance dynamics and the role of plasmid transfers and environmental reservoirs in the hospital setting. Over 13 months, routine clinical diagnostics identified recurring isolates of carbapenem-resistant Citrobacter species carrying Klebsiella pneumoniae carbapenemases (KPCs) and/or OXA-48-like carbapenemases from patient screening and hospital drain samples. While routine diagnostic approaches provided limited insights into the carbapenem resistance dynamics, we show that near-complete de novo assembly of chromosomes and plasmids by long-read nanopore sequencing allowed for high-resolution strain identification, plasmid profiling, and antibiotic resistance gene detection. Notably, genomically nearly indistinguishable Citrobacter freundii of the high-risk sequence type ST91 genomes were recovered from screening samples collected in the same hospital room 1 year apart. We further provide evidence of a KPC-2-encoding IncN plasmid that is likely to have spread across bacterial species and between patient and drain isolates, which emphasizes the role of contaminated drains in the persistence and dissemination of antimicrobial resistance within the hospital environment. Overall, this study demonstrates the value of long-read nanopore sequencing for uncovering the complex dynamics of carbapenem resistance spread and persistence in the hospital setting and its potential implications for infection prevention and control.

1 January 2023
Verified
Conference Paper
Open access
ESEla Sauerborn
Ela Sauerborn
TRTim Reska
Tim Reska
YHYoussef Hamway
Youssef Hamway
LULara Urban
Lara Urban
Bloodstream infections have become one of the main causes of hospital mortality with an estimated five million deaths per year globally. Recent trends have shown an increase in the proportion of multi-drug resistant gram-negative bacteria as causative agents. These strains represent the biggest challenge in treating bloodstream infections, as resistant infections are associated with higher mortality and longer hospital stays due to delayed and/or inappropriate therapy. The inappropriate and often broad-spectrum empirical therapy, in turn, increases selection pressure for resistant pathogens perpetuating the rise in antibiotic resistance. A rapid and accurate identification of the infection causing pathogen and its resistance patterns would facilitate early administration of appropriate antibiotic therapy leading to reduced resistance selection pressure and decreased mortality and morbidity. However, bloodstream infection diagnosis is currently mainly culture-based, which is typically time- and resource-consuming and has low clinical sensitivity and high culture bias. In this study, we have therefore started implementing metagenomic approaches using nanopore sequencing to overcome the limitations of culture-based approaches by making accurate real-time resistance predictions of all relevant bacterial strains to ultimately improve patient outcome. This study is conducted at the university hospital of TUM Rechts der Isar in Munich, Germany, since hospital mortality of sepsis patients in Germany is notably higher than in other high-income countries. We will here present our first results of sequencing DNA from routine blood cultures of ICU patients at TUM Rechts der Isar, and compare the accuracy and the turnaround time of our real-time genomics approach to the current state-of-the-art culture-based methods. Our preliminary results show a promising overlap in taxonomic and functional predictions with culture-based approaches, for example with respect to Klebsiella pneumoniae infection prediction and assessments of intrinsic Ampicillin and Piperacillin resistance. Our long-term aim is to develop fully integrated genomic and computational solutions to bring about an accurate, data-driven, and cost-effective approach for fast in-depth assessments of bloodstream infections directly at the point of care. This project has the potential to maximise the efficiency of antimicrobial therapy reducing the use of broad-spectrum antimicrobials and increasing survival rate in the context of bloodstream infections.

25 August 2025 in bioRxiv
Verified
Preprint
Open access
ESEla Sauerborn
Ela Sauerborn
Rhys Thomas WhiteRhys Thomas White
Rhys Thomas White
AKAnna-Lena Kalteis
Anna-Lena Kalteis
DGDaniel Gygax
Daniel Gygax
EFEbenezer Foster-Nyarko
Ebenezer Foster-Nyarko
LULara Urban
Lara Urban
The growing resistance of Enterobacterales to last-resort antibiotics such as carbapenems puts a significant burden on healthcare systems, also due to plasmids driving a rapid spread of carbapenem resistance. We here evaluate the use of long-read nanopore sequencing to investigate carbapenem resistance dynamics and the role of plasmid transfers and environmental reservoirs in the hospital setting. Over 13 months, routine clinical diagnostics identified recurring isolates of carbapenem-resistant Citrobacter species carrying Klebsiella pneumoniae carbapenemases (KPC) and/or OXA-48-like carbapenemases from patient screening and hospital drain samples. While routine diagnostic approaches provided limited insights into the carbapenem resistance dynamics, we show that near-complete de novo assembly of chromosomes and plasmids by long-read nanopore sequencing allowed for high-resolution strain identification, plasmid profiling, and antibiotic resistance gene detection. Notably, genomically nearly indistinguishable Citrobacter freundii of the high-risk sequence type ST91 genomes were recovered from screening samples collected in the same hospital room one year apart. We further provide evidence of a KPC-2 encoding IncN plasmid that is likely to have spread across bacterial species and between patient and drain isolates, which emphasizes the role of contaminated drains in the persistence and dissemination of resistances within the hospital environment. Overall, this study demonstrates the value of long-read nanopore sequencing for uncovering the complex dynamics of carbapenem resistance spread and persistence in the hospital setting, and its potential implications for Infection Prevention and Control. Impact statement: This study demonstrates how long-read nanopore sequencing can resolve the complex dynamics of plasmid-mediated antimicrobial resistance in clinical and environmental samples within the hospital setting. By linking patient- and drain-derived isolates through near-complete de novo assemblies, we reveal hidden reservoirs and dynamics behind the persistence of cabapenem resistance over extended time periods. This work shows how long-read sequencing approaches can uncover resistance dynamics that are missed using standard diagnostic methods, with implications for infection control and surveillance. Data Summary: The study sequences are available at the National Center for Biotechnology Information (NCBI) under BioProject accession number PRJNA1297122. The raw sequence read data is available at NCBI sequence read archive (SRA ( https://www.ncbi.nlm.nih.gov/sra )) under accession numbers SRR34727947-59. The chromosomal assemblies of all ST91 strains are available at NCBI GenBank under the Biosample accession numbers SAMN50449475-80. All other supporting data are provided in the article and supplementary data files.